• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用标准化评分系统预测巩膜炎患者的治疗反应

Prediction of response to treatment in patients with scleritis using a standardised scoring system.

作者信息

McCluskey P, Wakefield D

机构信息

Laboratory of Ocular Immunology, School of Pathology, University of NSW, Australia.

出版信息

Aust N Z J Ophthalmol. 1991 Aug;19(3):211-5. doi: 10.1111/j.1442-9071.1991.tb00663.x.

DOI:10.1111/j.1442-9071.1991.tb00663.x
PMID:1958366
Abstract

Scleritis is a severe chronic inflammation of the eye wall. High-dose corticosteroids and other immunosuppressive drugs are often required to control the inflammatory process. With the development of new and potentially more effective treatment modalities for scleritis has emerged the need for an accurate and reproducible system for quantifying the severity of scleritis and evaluating the response of individual patients to treatment. We have developed a quantitative scoring system, based on common clinical signs of scleritis, and evaluated it in 24 patients with scleritis. Our results indicate that this system is simple, rapid, reproducible and useful in grading the severity of scleritis and in predicting the response of patients to systemic immunosuppressive therapy.

摘要

巩膜炎是一种严重的眼壁慢性炎症。通常需要大剂量皮质类固醇和其他免疫抑制药物来控制炎症过程。随着针对巩膜炎的新的且可能更有效的治疗方式的发展,出现了对一种准确且可重复的系统的需求,该系统用于量化巩膜炎的严重程度并评估个体患者对治疗的反应。我们基于巩膜炎的常见临床体征开发了一种定量评分系统,并在24例巩膜炎患者中对其进行了评估。我们的结果表明,该系统在对巩膜炎严重程度进行分级以及预测患者对全身免疫抑制治疗的反应方面简单、快速、可重复且有用。

相似文献

1
Prediction of response to treatment in patients with scleritis using a standardised scoring system.使用标准化评分系统预测巩膜炎患者的治疗反应
Aust N Z J Ophthalmol. 1991 Aug;19(3):211-5. doi: 10.1111/j.1442-9071.1991.tb00663.x.
2
Current concepts in the management of scleritis.巩膜炎治疗的当前概念
Aust N Z J Ophthalmol. 1988 Aug;16(3):169-76. doi: 10.1111/j.1442-9071.1988.tb01206.x.
3
Episcleritis and scleritis: clinical features and treatment results.表层巩膜炎和巩膜炎:临床特征与治疗结果
Am J Ophthalmol. 2000 Oct;130(4):469-76. doi: 10.1016/s0002-9394(00)00710-8.
4
Comparative study of ophthalmological and serological manifestations and the therapeutic response of patients with isolated scleritis and scleritis associated with systemic diseases.
Arq Bras Oftalmol. 2011 Nov-Dec;74(6):405-9. doi: 10.1590/s0004-27492011000600004.
5
Scleritis therapy.巩膜炎治疗。
Ophthalmology. 2012 Jan;119(1):51-8. doi: 10.1016/j.ophtha.2011.07.043. Epub 2011 Oct 19.
6
[Scleritis, clinical features, etiologies and treatment: a case series of 32 patients].[巩膜炎:临床特征、病因及治疗——32例病例系列研究]
Rev Med Interne. 2014 Aug;35(8):491-7. doi: 10.1016/j.revmed.2013.09.013. Epub 2013 Nov 6.
7
Therapeutic decision in anterior scleritis: our experience at a tertiary care eye center.
J Fr Ophtalmol. 2005 Dec;28(10):1065-9. doi: 10.1016/s0181-5512(05)81139-8.
8
An analysis of therapeutic decision for scleritis.巩膜炎治疗决策分析
Ophthalmology. 1993 Sep;100(9):1372-6. doi: 10.1016/s0161-6420(93)31473-9.
9
[Scleritis: clinical characteristics, systemic associations, treatment and outcome in 100 patients].[巩膜炎:100例患者的临床特征、全身关联、治疗及预后]
Arq Bras Oftalmol. 2009 Mar-Apr;72(2):231-5. doi: 10.1590/s0004-27492009000200019.
10
Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey.土耳其 2 家三级眼科中心的巩膜炎患者的临床特征、预后和治疗结果。
Cornea. 2010 Jan;29(1):26-33. doi: 10.1097/ICO.0b013e3181ac9fad.

引用本文的文献

1
Adalimumab plus Conventional Therapy versus Conventional Therapy in Refractory Non-Infectious Scleritis.阿达木单抗联合传统疗法与传统疗法治疗难治性非感染性巩膜炎的对比研究
J Clin Med. 2022 Nov 11;11(22):6686. doi: 10.3390/jcm11226686.
2
Development and Implementation of the AIDA International Registry for Patients with Non-Infectious Scleritis.AIDA国际非感染性巩膜炎患者注册库的建立与实施
Ophthalmol Ther. 2022 Apr;11(2):887-897. doi: 10.1007/s40123-022-00466-2. Epub 2022 Jan 29.
3
The clinical presentation and treatment outcomes of ocular tuberculosis: a 5-year experience in an endemic area.
眼部结核的临床表现和治疗结果:在一个流行地区的 5 年经验。
Int Ophthalmol. 2021 Sep;41(9):3199-3209. doi: 10.1007/s10792-021-01886-y. Epub 2021 May 26.
4
Scleritis: Differentiating infectious from non-infectious entities.巩膜炎:区分感染性与非感染性病因。
Indian J Ophthalmol. 2020 Sep;68(9):1818-1828. doi: 10.4103/ijo.IJO_2032_20.
5
Clinical Profile and Treatment Response of Patients with Ocular Inflammation due to Presumed Ocular Tuberculosis: A Retrospective Study.疑似眼结核所致眼部炎症患者的临床特征及治疗反应:一项回顾性研究
Turk J Ophthalmol. 2019 Sep 3;49(4):188-193. doi: 10.4274/tjo.galenos.2019.05874.
6
Clinical characteristics of scleritis patients with emphasized comparison of associated systemic diseases (anti-neutrophil cytoplasmic antibody-associated vasculitis and rheumatoid arthritis).强调伴发系统性疾病(抗中性粒细胞胞质抗体相关性血管炎和类风湿关节炎)比较的巩膜炎患者的临床特征。
Jpn J Ophthalmol. 2019 Sep;63(5):417-424. doi: 10.1007/s10384-019-00674-7. Epub 2019 Jun 10.
7
Iontophoretic delivery of dexamethasone phosphate for non-infectious, non-necrotising anterior scleritis, dose-finding clinical trial.经皮离子电渗递药系统给予磷酸地塞米松治疗非感染性、非坏死性前部巩膜炎的剂量探索临床试验。
Br J Ophthalmol. 2018 Aug;102(8):1011-1013. doi: 10.1136/bjophthalmol-2017-311610. Epub 2018 Apr 17.
8
[Diagnosis and treatment of episcleritis and scleritis].[巩膜表层炎和巩膜炎的诊断与治疗]
Ophthalmologe. 2016 Sep;113(9):797-810. doi: 10.1007/s00347-016-0344-3.
9
Anterior segment spectral domain optical coherence tomography imaging of patients with anterior scleritis.前巩膜炎患者的眼前节谱域光学相干断层扫描成像
Int Ophthalmol. 2016 Aug;36(4):499-508. doi: 10.1007/s10792-015-0153-8. Epub 2015 Nov 23.
10
Biologic therapy for refractory scleritis: a new treatment perspective.难治性巩膜炎的生物治疗:一种新的治疗视角。
Int Ophthalmol. 2015 Dec;35(6):903-12. doi: 10.1007/s10792-015-0124-0. Epub 2015 Aug 29.